High intensity statins are associated with greatest reduction in mortality
BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6048 (Published 10 November 2016) Cite this as: BMJ 2016;355:i6048- Jacqui Wise
- London
Patients with atherosclerotic cardiovascular disease who received the highest intensity statin treatment showed the greatest reductions in mortality, data from more than half a million patients have shown.1
The retrospective cohort analysis published in JAMA Cardiology showed that high intensity statins were associated with a small but significant survival advantage compared with moderate intensity statins, including among patients over 75 years.
The researchers examined one year cardiovascular mortality by intensity of statin therapy among 509 766 adults with atherosclerotic cardiovascular disease treated in the Veterans Affairs healthcare system. The average age of the patients was …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.